Intelligent Bio Solutions (INBS)

Intelligent Bio Solutions (INBS) Financial Statements


Intelligent Bio Solutions Financial Overview

Intelligent Bio Solutions's market cap is currently ―. The company's EPS TTM is $-3.786; its P/E ratio is -0.61; Intelligent Bio Solutions is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 764.06K$ 796.09K$ 131.81K$ 457.06K$ 356.68K
Gross Profit$ 199.25K$ 232.33K$ -261.75K$ 33.05K$ 244.04K
EBIT$ -1.94M$ -2.39M$ -2.61M$ -6.27M$ -351.78K
EBITDA$ -1.65M$ -2.09M$ -2.44M$ -5.87M$ 46.38K
Net Income Common Stockholders$ -1.97M$ -2.43M$ -2.64M$ -6.36M$ -420.60K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.12M$ 186.40K$ 1.54M$ 2.28M$ 2.91M
Total Assets$ 8.83M$ 8.70M$ 10.35M$ 10.67M$ 18.05M
Total Debt$ 1.08M$ 1.16M$ 1.34M$ 1.69M$ 1.88M
Net Debt$ -38.04K$ 973.11K$ -201.56K$ -589.84K$ -1.04M
Total Liabilities$ 5.67M$ 7.46M$ 6.67M$ 4.74M$ 7.78M
Stockholders Equity$ 3.28M$ 1.36M$ 3.80M$ 6.03M$ 10.35M
Cash Flow-
Free Cash Flow$ -2.93M$ -1.31M$ -584.34K$ -2.52M$ -2.38M
Operating Cash Flow$ -2.87M$ -1.31M$ -584.34K$ -2.52M$ -2.38M
Investing Cash Flow$ -56.67K-$ -181.75K$ 173.80K$ -211.30K
Financing Cash Flow$ 3.79M-$ 46.11K$ 1.72M$ -328.41K
Currency in USD

Intelligent Bio Solutions Earnings and Revenue History

Intelligent Bio Solutions Debt to Assets

Intelligent Bio Solutions Cash Flow

Intelligent Bio Solutions Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis